Disclosures for "Characterizing the Effects of Progranulin Reduction on Tau Pathology and Phenotypes in a Mouse Model of Tauopathy"
-
An immediate family member of Miss Bhagwagar has received personal compensation for serving as an employee of three different biotech companies unrelated to the present submission.
-
Dr. Takahashi has nothing to disclose.
-
Dr. Strittmatter has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Allyx. Dr. Strittmatter has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Proteowise. Dr. Strittmatter has stock in Allyx. Dr. Strittmatter has stock in Proteowise. Dr. Strittmatter has stock in ReNetX. The institution of Dr. Strittmatter has received research support from Proteowise. Dr. Strittmatter has received intellectual property interests from a discovery or technology relating to health care. Dr. Strittmatter has received intellectual property interests from a discovery or technology relating to health care. Dr. Strittmatter has received intellectual property interests from a discovery or technology relating to health care.